ASH 2018 Caudia Stege HOVON 143

Caudia Stege PhD student, Amsterdam UMC, Amsterdam

 

Efficacy and Tolerability of Ixazomib, Daratumumab and Low Dose Dexamethasone (IDd) in Unfit and Frail Newly Diagnosed Multiple Myeloma (NDMM) Patients; First Interim Safety Analysis of the Phase II HOVON 143 Study

 

https://ash.confex.com/ash/2018/webprogram/Paper114668.html

 

0119HEM1092342
×

Ask Speakers

×

Medical Information Request